Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-12

FDA Approved: SODIUM PHOSPHATES — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sodium Phosphates submitted by Hospira, Inc. for the product's labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Phosphates (Sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous)

Snippet

SUPPL AP for SODIUM PHOSPHATES (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS)